The consolidation may have been done to facilitate a licensing deal, part of which could involve pharma purchasing an equity stake in Neuren (on top of an upfront payment and royalties). The consolidated registry would be more attractive to pharma, as opposed to having billions of shares on issue and greater share price fluctuations.
- Forums
- ASX - By Stock
- If I did see this correctly
The consolidation may have been done to facilitate a licensing...
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 400 | 13.960 |
3 | 2997 | 13.950 |
1 | 1828 | 13.930 |
Price($) | Vol. | No. |
---|---|---|
14.070 | 3070 | 3 |
14.080 | 323 | 2 |
14.100 | 1828 | 1 |
14.130 | 1828 | 1 |
14.150 | 1828 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |